Lupin Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Lupin Ltd.

Lupin Ltd. | Ownership

Companies that own Lupin Ltd.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Life Insurance Corp. of India

12,100,102

2.68%

0.17%

06/30/2018

ICICI Prudential Asset Management Co. Ltd.

10,775,432

2.38%

3,463,313

0.81%

08/31/2018

The Vanguard Group, Inc.

7,521,581

1.66%

-36,032

07/31/2018

BlackRock Fund Advisors

6,396,270

1.42%

-5,670

09/06/2018

Norges Bank Investment Management

6,261,590

1.39%

379,551

0.01%

06/30/2018

Genesis Investment Management LLP

6,231,332

1.38%

-4,638,062

0.4%

12/31/2017

Comgest SA

5,841,970

1.29%

1,310,357

0.35%

06/30/2018

Franklin Templeton Asset Management (India) Pvt Ltd.

4,743,432

1.05%

-699,999

0.85%

08/31/2018

L&T Investment Management Ltd.

3,655,299

0.81%

189,600

0.93%

07/31/2018

GIC Pte Ltd. (Investment Management)

3,600,882

0.8%

-1,166,602

0.07%

03/31/2018

About Lupin

View Profile

Address	B/4 Laxmi Towers Mumbai Maharashtra 400051 India
Employees	-
Website	http://www.lupinworld.com
Updated	09/14/2018
Lupin Ltd. engages in the manufacture of pharmaceutical products. Its offers branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The firm caters to the cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infectives, nonsteroidal anti-inflammatory drug therapy, anti-tuberculosis, and cephalosporins industry segments.